Country for PR: Indonesia
Contributor: Antara News Agency
Friday, November 23 2018 - 03:08
AsiaNet
Indonesia's Medicine Regulator Holds the First Meeting of the Heads of NMRAs of OIC Countries Towards Medicines and Vaccines Self Reliance
JAKARTA, Indonesia, Nov. 23, 2018/Antara-AsiaNet/--

Jakarta - Indonesia's National Agency for Drug and Food Control (BPOM) held the 
First Meeting of the Heads of National Medicines Regulatory Authorities (NMRAs) 
from the Organization of Islamic Cooperation (OIC) member states in Jakarta, on 
November 21-22, 2018.

About 32 OIC member states, OIC institutions, as well as international 
development partners (WHO, UNICEF and IDB) and pharmaceutical and vaccine 
industry associations from OIC member states participated in this event which 
discussed a collaboration to help improve the regulatory capacity and the 
production of pharmaceutical industry in achieving self-reliance and 
accessibility of medicines including vaccines in the OIC member states.

The diverse condition of political and economies in OIC member states made 
several limitation of access towards medicine and vaccines in some of OIC 
member states. 

Especially in conflicting and low-income countries which their mortality rates 
due to diseases still in high level. Moreover, infectious diseases are still a 
big problem for a number of the OIC member states.

Indonesia has been a member of the Pharmaceutical Inspection Co-operation 
Scheme (PICs) along with 49 other countries, in which only four OIC member 
states are included, namely, Indonesia, Malaysia, Turkey and Iran. The 
Indonesian membership in PICs proves the ability of Indonesia's BPOM as a 
regulator that ensures medicines produced by Indonesia meet the international 
standards and are recognized worldwide, and thus can be exported. 

Indonesia through Bio Farma has exported vaccines to 141 countries, including 
49 OIC member states.

"With its capabilities, Indonesia, through the national vaccine and serum 
manufacturer PT Bio Farma, has been appointed as the Center of Excellence (CoE) 
in vaccine for the OIC member states," said the Head of BPOM Penny K. Lukito.

In terms of vaccines production capabilities, Indonesia is one of leading 
countries among member of OIC. 

Moreover, vaccines produced by Indonesia have received Pre-Qualification status 
from WHO (PQ-WHO), which confirms that the product have met international 
quality, safety and standards.

The results of the meeting with the theme "Strengthening Collaboration Amongst 
the OIC NMRAs towards Self-Reliance of Medicines and Vaccines" will be 
formulated in a document named "Jakarta Declaration". 

This declaration contains commitments of the Heads of the Medicine Regulatory 
Authority of the OIC member states to improve the health quality of people and 
ensure their prosperity through the self-reliance of the production of 
medicines and vaccines that are safe, efficacious and qualified.

In addition to Jakarta Declaration, the meeting also produced "Plan of Action" 
which comprises various programs to realize medicine self-reliance for the OIC 
member states through piloting of the production of medicines and vaccines, 
producing generic medicines, developing biotechnology and bio similar 
medicines, and others.

This cooperation is aimed at jointly developing new products or certain types 
of vaccines that cannot be produced in the OIC region.

More information contact: 
HALO BPOM Contact Center
Tel:+62 1-500-533,
SMS +62-8121-9999-533, 
halobpom@pom.go.id,
twitter @BPOM_RI, or
Consumer Complaint Service Unit (ULPK) Center / POM Center throughout Indonesia

SOURCE: Indonesia's National Agency for Drug and Food Control 

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=325120

   Caption: Delegates of First Meeting of the Heads of National Medicines 
Regulatory Authorities (NMRAs) from the Organization of Islamic Cooperation 
(OIC) member states in Jakarta, on November 21-22, 2018.

Translations

Arabic